Total Funding
33
66
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
240947
Cedars Health develops a minimally invasive implant procedure for prostate enlargement.
About the Company
Cedars Health is developing a minimally invasive implant to surgically address benign prostatic hyperplasia (BPH). BPH is a noncancerous prostate enlargement that obstructs the urinary channel, causes urinary problems, and decreases the quality of life for 35 million men in the US and 500 million men worldwide. They are developing a cost-effective
BPH treatment option that is without complications to make it more available and accessible for the patients.
